TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference
Rhea-AI Summary
TELA Bio (NASDAQ: TELA), a medical technology company specializing in soft-tissue reconstruction solutions, has announced its participation in the upcoming Canaccord Genuity 45th Annual Growth Conference. The company's management team will deliver a presentation on August 13th, 2025, at 10:00 am ET. Investors and interested parties can access both the live presentation and archived webcast through the company's investor relations website at ir.telabio.com.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, TELA gained 0.52%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
MALVERN, Pa., July 23, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in the Canaccord Genuity 45th Annual Growth Conference.
TELA’s management is scheduled to present at the Canaccord Genuity 45th Annual Growth Conference at 10:00 am ET on August 13th, 2025. Interested parties can access the live and archived webcast at ir.telabio.com.
About TELA Bio, Inc.
TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit www.telabio.com.
Investor Contact
Louisa Smith
ir@telabio.com
FAQ
When is TELA Bio presenting at the Canaccord Genuity Growth Conference 2025?
How can investors access TELA Bio's Canaccord conference presentation?
What does TELA Bio (NASDAQ: TELA) specialize in?
Which conference is TELA Bio participating in during August 2025?
